Results
1 -
10 of
31
(Click
here to explore results)
- Hazardous Reagent Substitution: A Pharmaceutical Perspective, Chapter 8 New Directions from Academia. Manavi Yadav, Sriparna Dutta, Rakesh Kumar Sharma
, 2018
, Pages 130-167
- Biophysical Approaches Determining Ligand Binding to Biomolecular Targets: Detection, Measurement and Modelling, Chapter 9 Characterisation of Ligand Binding by Calorimetry. Ernesto Freire, Yuko Kawasaki, Adrian Velazquez-Campoy, Arne Schön
, 2011
, Pages 275-299
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 9 Pharmacokinetics and Metabolism of Compounds that Mimic Enzyme Transition States. Iain Gardner, Chris Barber, Martin Howard, Aarti Sawant, Kenny Watson
, 2010
, Pages 390-459
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 13 Cobicistat and Ritonavir as Pharmacoenhancers for Antiviral Drugs. Lianhong Xu, Manoj C. Desai
, 2013
, Pages 451-481
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 8 Peptidomimetics and Peptides as Drugs: Motifs Incorporated to Enhance Drug Characteristics. Tracey Boyden, Mark Niosi, Alfin Vaz*
, 2010
, Pages 370-389
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- Drug Design Strategies: Quantitative Approaches, Chapter 5 Contribution of Structure-Based Drug Design to the Discovery of Marketed drugs. Alexander A. Alex, David S. Millan
, 2012
, Pages 108-163
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets. Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27
- Computational and Structural Approaches to Drug Discovery: Ligand-Protein Interactions, Chapter 7 Combating Drug Resistance – Identifying Resilient Molecular Targets and Robust Drugs. Celia A. Schiffer
, 2008
, Pages 127-133
- Green Chemistry Strategies for Drug Discovery, Chapter 13 The Business Case for Green Chemistry in Drug Discovery. Joseph M. D. Fortunak, Martins O. Emeje, Harriet Kammendi, Ermias L. Tilahun, Xiang S. Wang
, 2015
, Pages 280-313